Danaher | DHR - Aktuelle Verpflichtungen





Aktuelle Verpflichtungen Veränderung Datum
Abbott USD 18.38B 1.88B 2026-03
Agilent USD 2.27B 35M 2026-03
Align Technology USD 1.91B 14.16M 2026-03
Becton, Dickinson and Co. USD 8.51B 254M 2026-03
Bio Techne USD 153.28M 12.85M 2026-03
Bio-Rad Laboratories USD 917M 400M 2026-03
Boston Scientific USD 4.57B 868M 2026-03
Bruker USD 1.36B 75.9M 2026-03
Charles River Laboratories USD 1.09B 26.61M 2026-03
Danaher USD 7.46B 653M 2026-03
Dentsply International USD 1.21B 136M 2026-03
Edwards Lifesciences USD 1.41B 404.7M 2026-03
ESCO Technologies USD 500.36M 18.03M 2026-03
Fortive USD 2.19B 61.3M 2026-03
Henry Schein USD 3.3B 69M 2026-03
Illumina USD 1.57B 19M 2026-03
Intuitive Surgical USD 2.51B 3.2M 2026-03
IQVIA Holdings USD 8.33B 9M 2026-03
Keysight Technologies USD 2.65B 844M 2026-03
Laboratory Of America USD 2.64B 182.5M 2026-03
Medtronic USD 9.5B 440M 2025-12
Mettler Toledo International USD 1.11B 89.76M 2026-03
Myriad Genetics USD 130.2M 3.6M 2026-03
OraSure Technologies USD 44.08M 4.29M 2026-03
Quest Diagnostics USD 2.18B 101M 2026-03
Quidel USD 962.4M 3.7M 2026-03
Repligen USD 126.21M 9.62M 2026-03
Revvity USD 1.24B 92.6M 2026-03
Roper Industries USD 3.58B 148M 2026-03
Stryker USD 6.32B 1.48B 2026-03
Thermo Fisher Scientific USD 14.62B 568M 2026-03
Waters USD 1.24B 11.8M 2025-12
Zimmer Biomet Holdings USD 2.86B 280.6M 2026-03